Stay updated on PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Sign up to get notified when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.

Latest updates to the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA notice about NIH terminology changes appears above the ClinicalTrials.gov page, and the site revision changes from v3.7.1 to v3.7.2. The requested study record remains unavailable behind a 403 error.SummaryDifference1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer site revision changes from v3.7.0 to v3.7.1; the page remains a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the usual study record content with an inaccessible error screen. The change includes an added 403 header and HTML, and deletions remove the standard study data and navigation.SummaryDifference21%

- Check43 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating a new release of the ClinicalTrials.gov page content. This update is likely administrative and does not change the study information presented to users.SummaryDifference0.0%

- Check57 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, signaling a minor update to the page’s metadata. This update does not modify the study details or substantive content shown on the page.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 to reflect a newer version of the page.SummaryDifference0.0%

Stay in the know with updates to PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.